Matches in Wikidata for { <http://www.wikidata.org/entity/Q65538194> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q65538194 description "clinical trial" @default.
- Q65538194 description "ensayu clínicu" @default.
- Q65538194 description "klinisch onderzoek" @default.
- Q65538194 description "клінічне випробування" @default.
- Q65538194 name "Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control" @default.
- Q65538194 name "Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control" @default.
- Q65538194 type Item @default.
- Q65538194 label "Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control" @default.
- Q65538194 label "Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control" @default.
- Q65538194 prefLabel "Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control" @default.
- Q65538194 prefLabel "Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control" @default.
- Q65538194 P1050 Q65538194-F3A9707B-D582-448E-89FD-FCED502029C9 @default.
- Q65538194 P1132 Q65538194-7B74886B-5893-429A-9EC8-224CFCDFBB2C @default.
- Q65538194 P1476 Q65538194-5C94E9AA-D2E0-4C39-BA7C-0CF0EF9F5821 @default.
- Q65538194 P17 Q65538194-0897E55B-66A9-49A3-A60B-3DD161595B1D @default.
- Q65538194 P2899 Q65538194-02824FDE-9944-4E62-BD4C-74CD254EA6A9 @default.
- Q65538194 P3098 Q65538194-9C9E29C5-999C-4D66-9077-905B48B787E1 @default.
- Q65538194 P31 Q65538194-14C1B42C-F20F-42F5-9FF5-46B3DF051D12 @default.
- Q65538194 P4135 Q65538194-5771B84F-C444-4830-AB71-B337264667CE @default.
- Q65538194 P4844 Q65538194-BE886C3C-2286-4C82-8F4C-537E115CAD9D @default.
- Q65538194 P4844 Q65538194-F65FEB27-55CB-4DA9-9B1B-42EE9E8C3286 @default.
- Q65538194 P580 Q65538194-75224410-B8DA-4554-BFD9-4453DE50DAD4 @default.
- Q65538194 P582 Q65538194-E70FD118-9675-4350-8E20-E465832F57FA @default.
- Q65538194 P6099 Q65538194-A73B5DAA-5EFE-4D1F-80E5-B0E1B4E1D48E @default.
- Q65538194 P8363 Q65538194-5A5EDE96-A064-4ABE-BEF0-6A8C62AADF5C @default.
- Q65538194 P1050 Q12206 @default.
- Q65538194 P1132 "+390" @default.
- Q65538194 P1476 "Safety and Efficacy of Insulin Glargine Injection [rDNA Origin] Treatment in Place of the TZD or the Sulfonylurea or Metformin in Triple Agent Therapy for T2DM Adult Subjects With Unsatisfactory Control" @default.
- Q65538194 P17 Q30 @default.
- Q65538194 P2899 "+18" @default.
- Q65538194 P3098 "NCT00283049" @default.
- Q65538194 P31 Q30612 @default.
- Q65538194 P4135 "+79" @default.
- Q65538194 P4844 Q19484 @default.
- Q65538194 P4844 Q6042242 @default.
- Q65538194 P580 "2006-02-01T00:00:00Z" @default.
- Q65538194 P582 "2008-11-01T00:00:00Z" @default.
- Q65538194 P6099 Q42825046 @default.
- Q65538194 P8363 Q78089383 @default.